Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Frelaut

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Lancet Regional Health. Europe|July 23, 2024
Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort studyAdrien Rousseau, Stefan Michiels, Noémie Simon-Tillaux, et al.
Breast Cancer Research : BCR|May 29, 2020
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris areaPerrine Vuagnat, Maxime Frelaut, Toulsie Ramtohul, et al.
JNCI Cancer Spectrum|February 19, 2021
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer PatientsClémence Basse, Sarah Diakite, Vincent Servois, et al.
Drugs & Aging|May 15, 2025
Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical TrialsAna Vaz Ferreira, Matthieu Delaye, Arnaud Pages, et al.
Critical Reviews in Oncology/Hematology|November 25, 2023
Antibody drug conjugates in older patients: State of the artLayal Rached, Arthur Geraud, Maxime Frelaut, et al.
Molecular Oncology|August 5, 2020
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trialCélia Dupain, Julien Masliah-Planchon, Céline Gu, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Lancet Regional Health. Europe|July 23, 2024
Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort studyAdrien Rousseau, Stefan Michiels, Noémie Simon-Tillaux, et al.
Breast Cancer Research : BCR|May 29, 2020
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris areaPerrine Vuagnat, Maxime Frelaut, Toulsie Ramtohul, et al.
JNCI Cancer Spectrum|February 19, 2021
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer PatientsClémence Basse, Sarah Diakite, Vincent Servois, et al.
Drugs & Aging|May 15, 2025
Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical TrialsAna Vaz Ferreira, Matthieu Delaye, Arnaud Pages, et al.
Critical Reviews in Oncology/Hematology|November 25, 2023
Antibody drug conjugates in older patients: State of the artLayal Rached, Arthur Geraud, Maxime Frelaut, et al.
Molecular Oncology|August 5, 2020
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trialCélia Dupain, Julien Masliah-Planchon, Céline Gu, et al.
Pageof 3